Introduction {#Sec1}
============

Childhood obesity incidence has globally risen at an alarming rate during last decades. Although the increasing rates are apparently plateauing in some Western countries, it remains a serious challenge and a public health priority, given that obesity during childhood is associated with an increased risk of morbidity and mortality due to non-communicable diseases in adulthood^[@CR1]^.

The long-term metabolic consequences of childhood obesity are mainly associated with an excessive accumulation of body fat, which in turn leads to an increased risk to develop non-communicable diseases, like type 2 diabetes mellitus and cardiovascular diseases^[@CR2]^. However, the mechanistic pathways by which adiposity may induce metabolic perturbations are not fully understood^[@CR3]^. The identification in the early stages of childhood obesity of metabolic profiles potentially predicting obesity-related co-morbidities later in life should be considered not only a research topic, but also a clinical priority^[@CR4]^. Besides the well-known biochemical and anthropometric risk factors present in overweight/obese children and associated to metabolic/cardiovascular disturbances in adulthood, new players are emerging as potential markers of these conditions.

A wide array of volatile organic compounds (VOCs) is emanated from the human body via breath, saliva, blood, milk, skin secretions, urine, and faeces, as products of metabolic processes^[@CR5]^. Several studies have revealed that the metabolomics analysis of VOCs from biological fluids can give useful information for the clinical diagnosis and the therapeutic monitoring of a variety of pathologies, including gastrointestinal disorders and cancer^[@CR6],[@CR7]^. In particular, Alkhouri *et al*. have provided evidence on significant differences of the pattern of exhaled VOCs in obese children compared with lean controls, demonstrating that various breath VOCs could potentially be useful to gain insight into pathophysiological processes and pathways leading to the development of childhood obesity and its related complications^[@CR8]^.

Among the various biological fluids, urine shows specific features that make it an option of choice for volatile metabolomic profiling. Urine samples can be easily and non-invasively collected in large quantities and stored for long periods. They also offer higher concentrations of VOCs compared to other body fluids. A large body of evidence has revealed that urinary VOCs profiles contain rich information about individual physiological conditions, so that some urinary VOCs can be considered potential biomarkers in diagnosing or monitoring several pathological conditions, including diabetes, autism syndrome and different types of cancer^[@CR6],[@CR9]^. Very recently, Elliot *et al*. have examined, by proton (1 H) nuclear magnetic resonance (NMR) spectroscopy and ion exchange chromatography, urinary metabolites from urine samples collected over two 24-hour time periods, to characterize the metabolic patterns of adiposity in a large epidemiological study in the United States and UK. This study showed unforeseen dependencies and interconnectivities between specific urinary metabolites and biochemical pathways that are possibly involved in the pathogenesis of obesity^[@CR10]^.

The potential of urinary VOCs profiling as early diagnostic method has not been fully explored, both because of its complexity (containing numerous volatile compounds with different structure and a range of polarity, concentration and volatility) and of the analytical difficulties in identifying and quantifying volatile metabolites. Consequently, several analytical techniques have been developed for separation and concentration of VOCs from this biological fluid. Among them, solid-phase microextraction (SPME), a pre-concentration technology, which integrates sampling, extraction, concentration, and sample introduction into a single solvent-free step^[@CR11]^, can be successfully used to simplify this complexity, specifically when coupled to capillary gas chromatography--mass spectrometry (GC-MS)^[@CR12]^. Nowadays, urine analysis by SPME GC-MS has been well established as an easy, fast and reliable diagnostic tool allowing the identification of possible urinary disease-associated VOCs.

Aim of the present study was to evaluate, using SPME GC-MS, urinary metabolic signatures in a sample of normal-weight (NW) and overweight/obese (OW/Ob) children belonging to the Italian cohort of the I. Family study.

Results {#Sec2}
=======

Twenty-one OW/Ob (ten females and eleven males, age 12.4 ± 1.2 years, BMI 26.7 ± 4.2 kg/m^2^) and twenty-eight NW (sixteen females and twelve males, age 12.9 ± 1.5 years, BMI 19.5 ± 1.8 kg/m^2^) children were included in the study. The total energy intake, and the energy intake (% kcal) from fat, carbohydrates and proteins were comparable in the two groups (Table [1](#Tab1){ref-type="table"}). Similarly, no difference were observed between the two groups with regard to blood glucose, insulin, HbA1C, and HOMA index.Table 1Characteristic of the study population.**NwOw/ObP-value**N (m/f)28 (12/16)21 (11/10)Age (years)12.9 ± 1.512.5 ± 1.10.288BMI (Kg/m^2^)19.5 ± 1.826.7 ± 4.2\<0.001Height (cm)155.0 ± 8.8153.7 ± 8.20.364Weigth (Kg)47.2 ± 7.862.7 ± 13.9\<0.001Glucose (mg/dl)93.8 ± 5.994.1 ± 6.20.879HOMA-IR1.8 ± 1.21.9 ± 1.40.794Energy (Kcal/day)1715.9 ± 678.71748.0 ± 889.30.889Energy fat (%)32.0 ± 7.627.7 ± 7.40.057Energy carbohydrate (%)51.2 ± 8.355.4 ± 10.50.138Energy protein (%)16.3 ± 3.915.7 ± 6.10.658M ± SD.

Characterization of the volatile urinary metabolome under acidic and alkaline conditions {#Sec3}
----------------------------------------------------------------------------------------

### Determination of the urinary volatile profiles of overweight/obese and normal-weight children by SPME GC-MS {#Sec4}

Typical SPME GC-MS TIC chromatograms of urine samples from a NW and an OW/Ob child, reported, respectively, in Fig. [1a and b](#Fig1){ref-type="fig"}, show that very similar VOCs profiles were obtained from the urine of the two groups of subjects, when analysed under acid conditions.Figure 1Representative SPME GC-MS chromatograms of urine VOCs from a NW (**a**) and OW/Ob (**b**) child obtained under acidic pH.

On the other hand, different volatile profiles were clearly distinguished in the urine obtained from the two groups of subjects analysed under basic pH, as displayed in Fig. [2a and b](#Fig2){ref-type="fig"}, which show, respectively, representative SPME GC-MS TIC chromatograms of urine samples from a NW and an OW/Ob child analysed under alkaline conditions.Figure 2Representative SPME GC-MS TIC chromatograms of urine VOCs from a NW (**a**) and OW/Ob (**b**) child obtained under alkaline pH.

Identification of each metabolite was achieved by comparing the fragmentation patterns (in terms of presence and intensity of the signals) with those in the NIST 2005 and Wiley 2007 libraries and by evaluating their retention times, using an in-house retention-time library based on reference standard samples. Additionally, identification of volatile compounds was also accomplished by matching their retention indices (RI) (as Kovats indices)^[@CR13]^ with literature data, calculated in relation to the retention time of a C~8~-C~20~ n-alkanes series, with those of authentic compounds or literature data for similar chromatographic columns.

The identified metabolites included a variety of chemical structures: aldehydes, ketones, nitrogen compounds, terpenes, acids, alcohols, benzene derivatives, furan and sulphur-containing compounds and esters.

One hundred and ten and eighty-three metabolites were detected in samples from both NW and OW/Ob children under acid and alkaline conditions, respectively.

The fragment ion m/z values of the all identified urinary VOCs with the highest abundance within each fragmentation pattern, the matching percentage of the NIST and/or Wiley library, the experimental and literature reported Kovats index, the identification methods and their frequency of occurrence in OW/Ob and NW children are listed in Tables [2](#Tab2){ref-type="table"} and [3](#Tab3){ref-type="table"} for acidic and alkaline conditions, respectively.Table 2VOCs identified in the urine of OW/Ob and NW children under acid pH. Main fragment ion m/z, match percentage to the NIST 05 and/or Wiley 07 libraries, experimental (RIcal) and literature reported (RI) Kovats index, identification methods (ID) and percentage of occurrence are reported.Metabolitesm/zMatch per cent (%)RIcalRIIDPercentage of occurrence (%)NWOW/ObKetones Acetone4380MS/S100100 2-Butanone4390MS/S9391 2-Pentanone4372MS/S100100 3-Pentanone 2,4-dimethyl4364MS304 2-Pentanone 4-methyl435310081008RI/MS5965 2-Pentanone-3-methyl436010111013RI/MS5965 3-Hexanone439110571057RI/MS10096 4-Heptanone43/719111341131RI/MS100100 3-Heptanone43/726411601162RI/MS1817 2-Heptanone588711921191RI/MS96964-Octanone439012351236RI/MS3339 6-Methyl-5-hepten-2-one438713491347RI/MS3030 2-Nonanone586813951395RI/MS8178 Isophorone828614021607RI/MS4439 Pinocarvone81/1087615771585RI/MS93100 p-Menthone1129815041478RI/MS40 4-Methylacetophenone11994MS49Alcohols 2-Propanol4580MS/S4 Ethanol4572MS/S100100 3-Buten-2-ol 2-methyl718710481048RI/MS4156 Isoamyl alcohol557812231222RI/MS154 1-Hexanol565013591358RI/MS7465 3-Octanol598314021401RI/MS4148 1-Heptanol707214551454RI/MS5952 1-Hexanol-2-ethyl578615041503RI/MS9687 1-Octanol568015691566RI/MS/S8987 Isopulegol419515731574RI/MS269 Endo fenchol819415861579RI/MS/S3313 2-Furanmethanol989516741678RI/MS8991 1-Decanol558317761778RI/MS79 Nerol699117951794RI/MS/S---4 Geraniol6981MS/S119Aldehydes 2-Methyl butanal5759MS/S9391 3-Methyl butanal4464MS/S8178 Pentanal4490MS/S422 Hexanal449410881087RI/MS100100 Heptanal709311961195RI/MS4152 2-Hexanal (E)559312311230RI/MS/S4422 Furfural967814751474RI/MS3748 Myrtenal799516421642RI/MS7474 Benzaldehyde1059015371537RI/MS/S15--- Phellandral1099517381741RI/MS1122Acids Acetic acid438014631465RI/MS6752 Propanoic acid 2,2-dimethyl577215861582RI/MS3322 Nonanoic acid6094MS/S3330Terpenes α-Pinene939610201027RI/MS/S11--- α-Fenchene937210541071RI/MS/S3343 Camphene939210531053RI/MS44 Verbenene917011221126RI/MS7478 Phellandrene939011681177RI/MS5961 β-Myrcene938311711171RI/MS/S1517 α- Terpinene1219711831183RI/MS/S9387 1,5,8 p-menthatriene919412021210RI/MS4130 dl-limonene689712051206RI/MS/S7491 Eucalyptol939612151215RI/MS5252 cis β-ocymene937412511250RI/MS/S4130 γ- Terpinene939612581257RI/MS/S96100 trans β-ocymene938912641250RI/MS/S3030 p-cymene1199712841282RI/MS100100 m-cymene1199412901282RI/MS10096 α-Terpinolene93/1219812971297RI/MS/S9691 Tetrahydro linalool735914391431RI/MS/S8578 cis linalool oxide598014511451RI/MS/S8587 Dihydro myrcenol598014801473RI/MS8983 trans-linalool oxide599114791483RI/MS/S7861 Neroloxide687014841481RI/MS44 cis-theaspirane1389315161507RI/MS10096 Camphor959115291529RI/MS/S1122 Vitispirane1929515451543RI/MS100100 Linalool l719715571558RI/MS/S8583 1-Terpineol819615821581RI/MS5265 4-Terpineol719516101616RI/MS/S9387 γ-Valerolactone566016161617RI/MS1522 Hotrienol717816161616RI/MS---9 β-Cyclocitral1529416291623RI/MS4452 β-Terpineol719716291629RI/MS1517 Menthol71/81/959316541652RI/MS8583 Safranal1079516611648RI/MS726 β-Ocimenol (Z)938616611627RI/MS722 trans-pinocarveol929016671661RI/MS8991 α-Phellandren-8-ol947216801680RI/MS8583 Borneol958016901688RI/MS/S1126 Ocimenol939017121710RI/MS4448 α- Terpineol599116671677RI/MS/S8978 γ- Caprolactone858717191720RI/MS74 β- Phellandren-8-ol948017441778RI/MS7465 Carvone829717571751RI/MS/S5239 Naphtalene 1,2-dihydro-1,1,6-trimethyl1579717631751RI/MS8987 α-Bisabolene937217831778RI/MS9 Myrtenol799617951796RI/MS7478 δ-Caprolactone4287MS/S7856 Cadinene16189MS159 β-Damascenone6998MS/S100100 Carveol10970MS/S3022 p-Cymen-8-ol13590MS8187 Calacorene15793MS8974 Nerolidol6991MS/S7478Furans Furan6887MS/S100100 2-Methyl furan8270MS/S10096 2,5-Dimethyl furan9697MS/S100100 2,3,5-Trimethyl furan1106410631063RI/MS9687 2-Pentyl furan819012481243RI/MS9391Thiols Methanethiol4791MS100100 Thiophene 2-methylthio1308115411543RI/MS3726Others Methyl ethyl sulfide6190MS44 Dimethyl disulfide949710791071RI/MS100100 Dimethyl trisulfide1269713881384RI/MS10091 Benzene 1,2,3-trimethyl1059313461332RI/MS7474 Heptanenitrile828714021396RI/MS11 4-Acetyl-1-methylcyclohexene959015651568RI/MS1526 Table 3VOCs identified in the urine of OW/Ob and NW children under alkaline pH. Main fragment ion m/z, match percentage to the NIST 05 and/or Wiley 07 libraries, experimental (RIcal) and literature reported (RI) Kovats index, identification methods (ID) and percentage of occurrence are reported.Metabolitesm/zMatch per cent (%)RIcalRIIDPercentage of occurrence (%)NWOW/Ob**Ketones** Acetone4380MS/S100100 2-Butanone4364MS/S9383 2-Pentanone4372MS/S96100 4-Methyl-2-pentanone437210051008RI/MS2230 3-Hexanone438210571057RI/MS7074 5-Methyl-3-hexanone576410821068RI/MS6678 2-Hexanone437410881088RI/MS3043 4-Heptanone439011371131RI/MS8996 3-Penten-2-one697211401138RI/MS2217 3-Penten-2-one-4-methyl836411431139RI/MS4443 2-Methyl-4-heptanone57761161---MS1822 3-Heptanone576011651162RI/MS1830 2-Heptanone439111961198RI/MS100100 4-methyl-2-heptanone438012221224RI/MS5561 4-Octanone578712381236RI/MS426 3-Octanone579012701272RI/MS5256 3-Hepten-2-one559013161274RI/MS3748 3-Methylcyclohexanone696413361333RI/MS2630 3-Ethylcyclopentanone83641342---MS3743 6-Methyl-5-hepten-2-one437813491347RI/MS9696 2-Cyclopenten-1-one 2-methyl967213781373RI/MS413 3-Octen-2-one558114141414RI/MS4861 Pinocarvone818715771575RI/MS9696 Seudenone828315971592RI/MS10096 Pulegone819116601662RI/MS6561 Acetophenone1058716661669RI/MS4856 Piperitone829417491748RI/MS9674 Methylacetophenone1196417881793RI/MS1526**Alcohols** Ethanol4580MS/S100100 Isobutyl alcohol436411061107RI/MS159 1-Butanol568611591158RI/MS93100 2-Methyl −4-pentanol456411801181RI/MS2243 2-hexanol457211801179RI/MS2235 3-Buten-1-ol- 3-methyl568012641264RI/MS4452 1-Pentanol427812671270RI/MS9391 1-Hexanol567213621358RI/MS100100 Cyclohexanol576214061407RI/MS3026 2,4,4-Trimethyl-1-pentanol578314021326RI/MS10096 1-Octen-3-ol575014501450RI/MS1122 1-Heptanol708614631463RI/MS8987 1-Hexanol-2-ethyl578015031503RI/MS100100 1-Octanol569115651566RI/MS/S100100 D-Fenchyl alcohol819015891588RI/MS5556 Benzyl alcohol7995MS/S100100**Nitrogen compounds** Trimethylamine5890MS/S9696 Dimethylamine4486MS/S100100 Isoxazole6943MS5965 Piperidine849111161115RI/MS9396 Pyridine797611921193RI/MS4835 2,6-Dimethyl pyridine1079112611266RI/MS3735 2-Methyl pyrazine949012771274RI/MS100100 2,5-Dimethyl pyrazine1088713331332RI/MS5948 Formammide N,N-dimethyl736413381328RI/MS417 2,6-Dimethyl pyrazine1088713391338RI/MS6361 Ethyl pyrazine1078713461344RI/MS4452 2,3-Dimethyl pyrazine1087613551355RI/MS7861 2,4,6-Trimethyl pyridine1219113751378RI/MS3043 Trimethyl pyrazine1227414101410RI/MS4422 Pyrazine 2-ethyl-6-methyl1218713911390RI/MS8991 Ethenyl pyrazine1069014421438RI/MS09 1 H Pyrrole678715241524RI/MS10096 1 H Pyrrole 2-methyl808615851580RI/MS7856 Pyrrole 4-ethyl-2-methyl94781730---MS8587 Formammide N,N-dibutyl729417851773RI/MS8183 1-Methyl-2-piperidone11360MS9396 1-Piperidinecarboxyaldehyde1139317811786RI/MS2226**Terpenes** 4-Terpineol719716081616RI/MS/S9391 Menthol716416531652RI/MS8574 trans Pinocarveol926416721661RI/MS9391 α-Terpineol599117171710RI/MS/S9387 Borneol956017241723RI/MS/S7491 Carvol829517561751RI/MS/S8165 Myrtenol7996 1795 1796RI/MS10091**Furans** 2,5-Dimethyl furan9690MS/S114 3-Acetoamidofuran83721369---MS5556 2-Acetylfuran957615161512RI/MS7474**Esters** 2-Butenoic acid ethyl ester69801165RI/MS1122 2-Hexenoic acid ethyl ester979713521357RI/MS09 Octanoic acid-2-methyl  ethyl ester102721385---MS/S04**Compounds contain sulfur** Dimethyl disulfide949610761071RI/MS9696 Disulfide methyl-2-propenyl1207212971296RI/MS4452 Trisulfide dimethyl1269113881389RI/MS6674 Dimethyl sulfone7962MS7078

### Data analysis of the SPME GC-MS data sets {#Sec5}

A preliminary exploratory data analysis was performed using PCA, excluding the presence of outliers in both the data sets on the basis of the DModX test and the Hotelling's T2 test (at level of 95%).

Statistical data analysis based on multivariate and univariate approaches performed on VOCs profiles obtained under acid pH did not show differences between the two analysed groups. The PLS-DA model built, considering the whole data set, did not pass the permutation test on the class response and the distribution of the AUC ROC in prediction, obtained during stability selection, showed median equal to 0.63 and 5^th^ percentile equal to 0.47. In addition, the minimum p-value of the t-test for the measured variables resulted to be 0.12 and the behaviour of the related ROC curves unsatisfactory.

On the other hand, a robust PLS-DA model was obtained considering the SPME GC-MS data acquired in alkaline conditions. In Fig. [3](#Fig3){ref-type="fig"} we report the score scatter plot of the discriminant model. Under stability selection, the distribution of the AUC ROC in prediction showed median equal to 0.91 and 5^th^ percentile equal to 0.64. The metabolites selected by stability selection were joined to those selected by t-test with False Discovery Rate and ROC obtaining a set of 14 putative markers, which seem to be crucial in the distinction of OW/Ob children and NW (Table [4](#Tab4){ref-type="table"}). Among these, the levels of 2-pentanone, 3-hexanone, 5-methyl-3-hexanone, 4-methyl-2-heptanone, 3-octanone, 2,4,4-trimethyl-1-pentanol, 1-hexanol, 2-hexanol, 1-heptanol, dimethyl sulfone, 2,4,6-trimethyl-pyridine and formamide N,N-dibutyl are higher in the urine of OW/Ob children than in NW. In contrast, 1 H pyrrole-2-methyl and 1-methyl-2-piperidone have a lower concentration in OW/Ob children compared to NW.Figure 3Score scatter plot of the PLS-DA model built considering the data set obtained under alkaline conditions. The model showed 2 components, R^2^ = 0.74 (p-value \< 0.001) and AUC ROC, calculated by 7-fold cross-validation, equal to 0.96 (p-value \< 0.001). NW children are indicated with white circles whereas OW/Ob subjects with dark grey circles. The PLS-DA model was post-transformed according to Stocchero & Paris (2016)^[@CR34]^. Table 4Selected VOCs identified in SPME GC-MS analysis under alkaline conditions.IDtype^\*^AUC ROC (95% CI)^\*\*^power ROC^§^spec^‡^sens^+^t-test p-valuepower t-test^†^q-value5-Methyl-3-hexanoneOW/Ob \> NW0.606--0.8990.891.000.522.5E-040.929.5E-031-HeptanolOW/Ob \> NW0.563--0.8790.790.790.713.4E-030.783.6E-024-Methyl-2-heptanoneOW/Ob \> NW0.543--0.8400.660.640.713.8E-030.773.6E-022-HexanolOW/Ob \> NW0.541--0.8150.600.790.526.4E-030.684.0E-02Dimethyl sulfoneOW/Ob \> NW0.548--0.8520.700.710.717.5E-030.724.0E-02Formammide N,N-dibutylOW/Ob \> NW0.515--0.8280.560.610.671.6E-020.565.0E-021-HexanolOW/Ob \> NW0.448--0.7820.290.710.572.1E-020.516.0E-022-PentanoneOW/Ob \> NW0.556--0.8810.780.820.672.2E-020.496.0E-022,4,6-Trimethyl-pyridineOW/Ob \> NW0.508--0.8040.490.680.622.7E-020.466.5E-023-HexanoneOW/Ob \> NW0.517--0.8290.570.640.712.8E-020.496.5E-023-OctanoneOW/Ob \> NW0.637--0.9030.930.750.815.0E-020.508.2E-022,4,4-Trimethyl-1-pentanolOW/Ob \> NW0.529--0.8370.620.541.007.6E-020.321.1E-011 H pyrrole-2-methylNW \> OW/Ob0.588--0.8620.800.610.901.3E-030.962.4E-021-Methyl-2-piperidoneNW \> OW/Ob0.526--0.8310.600.750.521.3E-020.774.9E-02^\*^OW/Ob \> NW indicates metabolites with concentration higher in the urine of OW/Ob children than in NW; NW \> OW/Ob indicates metabolites with lower concentration in OW/Ob children than in NW.^\*\*^AUC ROC (95% CI) = confidence interval of the Area Under the ROC curve at the level of 95%.^§^power ROC = power for identifying the observed AUC given a level of significance α = 0.05.^‡^spec = specificity.^+^sens = sensitivity.^†^power t-test = power for identifying the observed difference in the means given a level of significance α = 0.05.

Discussion {#Sec6}
==========

In the present paper, SPME GC-MS was used to evaluate for the first time the volatile urinary metabolic signatures associated with early obesity on a sample of children belonging to the Italian cohort of the I. Family study.

Urine sampling is a simple and safe alternative to more invasive investigations in children, and, as far as we are aware, this is the first study in which, in order to profile a wider range of urinary volatiles with different physicochemical properties, VOCs from urine samples of OW/Ob and NW children have been analysed under both acidic and alkaline conditions.

One hundred and ten and eighty-three VOCs were detected in samples from both NW and OW/Ob children under acid and alkaline conditions, respectively. Statistical data analysis based on multivariate and univariate approaches performed on volatiles profiles obtained under acid pH did not allow distinguishing the two analysed groups. On the other hand, a robust PLS-DA model was gained considering the large and heterogeneous SPME GC-MS set of data acquired under alkaline conditions, which also allowed the identification of fourteen VOCs putative biomarkers that seem to be crucial in differentiating OW/Ob children from NW.

A large number of VOCs in urine seems to arise from the bacterial action in the gut^[@CR5]^, while the presence of volatile metabolites in the gastrointestinal tract is believed to result from the complex interaction of colonocytes, human gut microflora and invading pathogens^[@CR14]^. Alkhouri *et al*. have reported that obese children have a unique pattern of VOCs compared with lean children showing that obesity, like other pathological disturbances, can induce the synthesis of new VOCs or a modification in the concentration of VOCs that are normally produced into the metabolic condition of an individual^[@CR8]^.

Specifically, alterations found in the pattern of VOCs can be reflective of changes and variations within the gastrointestinal environment, as demonstrated by a large body of evidence for the role of gut microbial dysbiosis in the pathophysiology of obesity and other gastrointestinal disorders^[@CR15]^.

The relationship between the intestinal microbiota and the immune system of the host could be a mediating factor in the development of obesity^[@CR16]^. Indeed, there is evidence that the gut microbiota can directly influence body weight in several ways^[@CR17]^. The relative abundance of bacterial species and the microbial diversity vary with the physiological state of the host. In particular, obesity is associated with both a reduced-diversity microbial community and an altered representation of bacterial genes^[@CR15]^.

Microbes produce about 300 volatile organic compounds in the human gut, whose systemic effects are unknown^[@CR18]^. Del Chierico *et al*. (2017) have demonstrated that the relative abundance of some species of bacteria (*Firmicutes* and *Bacteroidetes*) in obese children was similar to that of nonalcoholic fatty liver (NAFL) and nonalcoholic steatohepatitis (NASH) children. These microorganisms always present higher levels in patients compared to controls, while the level of other type of bacteria (*Oscillospira*) is decreased. Consequently, VOCs have huge potential as biomarkers specific of gastrointestinal and even metabolic diseases.

Data from the literature suggest a possible biological role for some, but not all, of the fourteen VOCs whose levels significantly differed in the two groups under study.

The up-regulation of some of the ketonic and alcoholic compounds, reaching statistical significance in the OW/Ob group vs NW, has been already observed in obese compared to normal-weight children and explained with a gut microbial dysbiosis in the obese subjects^[@CR17]^. In particular, 5-methyl-3-hexanone and 4-methyl-2-heptanone, belonging to the methyl-ketone group, were found statistically higher in OW/Ob than in NW children. These compounds can be produced by many species of bacteria and fungi from the respective alkanoic acid^[@CR19]^. Indeed, the other ketonic compounds, such as 2-pentanone, 3-hexanone and 3-octanone, can also be synthesized by bacteria^[@CR5]^.

With regard to alcohols, the abundance of 1-hexanol, 2-hexanol, 1-heptanol, 2,4,4-trimethyl-1-pentanol is increased in all OW/Ob children compared to NW. These findings can be explained with same results reported in Zhu *et al*. (2013), who have shown that there is a significant increase of Bacteroides in the obese and NASH groups, compared to the healthy group. The increase of these gut microbial bacteria, capable of producing alcohol, may explain why some alcoholic VOCs are more abundant in OW/Ob children compared to NW^[@CR20]^.

A more in depth assessment of the literature has allowed to retrieve different papers indicating that some bacterial species, present also in the human gut microbiome, may produce some of the compounds we found. Specifically, 5-methyl-3-hexanone, 2-pentanone, 3-octanone and 1-hexanol can be released by various actinomycetes in gut flora^[@CR21]--[@CR23]^.

The VOCs profile of OW/Ob compared to NW children also results in a higher urinary level of dimethyl sulfone in OW/Ob children. Sulphur containing compounds are formed by incomplete metabolism of sulphur containing amino acids in the transamination pathway. The levels of these compounds are known to be elevated in patients with altered liver function^[@CR24]^. Fatty liver disorders are very common in obese children and adolescents, reaching a prevalence of 40--50%^[@CR25]^. Interestingly, previous findings have demonstrated that sulphur-containing compounds are also associated to childhood obesity^[@CR8]^.

Our study confirms the results of recent papers indicating that certain urinary volatile compounds appeared to contribute to the metabolic signature of adiposity^[@CR8],[@CR10],[@CR17]^.

The VOCs associated with obesity in our study are indeed not consistent with those identified in other studies^[@CR8],[@CR10]^. Several factors may affect the different VOCs profiles observed in different settings, including environmental and dietary factors, methodological differences in sampling (urine/breath) and analytical detection techniques, and finally, characteristics of the populations under study. Of note, Elliot *et al*. (2015) reported about adult subjects, while in the Alkhouri *et al*. study (2015) a large proportion of affected children had severe obesity.

Moreover, although we did not report differences in caloric as well as macronutrient intake between OW/Ob children and NW, we cannot exclude those differences in specific dietary components may affect the VOCs profile. It has been suggested that both intra- and inter-variability in VOCs profile can be related to dietary habits^[@CR26]^. Consequently, the adoption of a standardized diet prior to the test can help to reduce variability in VOCs in future experimentations. Finally, the present cross-sectional analysis, with urinary VOCs determined at a single time point, by its nature excluded the identification of causality.

The absence of a blind validation set to test our findings is a limitation of the study. In spite of the robust and conservative procedure used for internal validation, a new set of subjects would be required to replicate the results of this pilot study and to confirm the selected putative markers.

Post-hoc power analysis suggested that the number of recruited subjects for each group was insufficient for some of the selected VOCs. We will take into account our results for designing new experiments with a sufficient statistical power able to improve the knowledge about the role of the VOCs in explaining the development and the progression of the obesity in children.

Finally, environmental chemical exposures possibly interfering with the urinary VOCs profile were not assessed in the present study.

In conclusion, our results suggest that there is potential for urinary VOCs, detected by SPME GC-MS, as metabolic biomarkers of childhood obesity. In particular, the hypothesis that altered urinary VOCs profiles may reflect gut dysbiosis or early impairment of the liver function deserves further investigation, particularly considering that urine sampling represents simple and safe alternative to more invasive procedures in children. While we recognize the limitations and the relative reliability of our analyses, these novel findings may be considered as hypothesis-generating, to be obviously confirmed by larger prospective investigations.

Methods {#Sec7}
=======

Experimental design and cohort {#Sec8}
------------------------------

The I.Family project (<http://www.ifamilystudy.eu>) aimed to assess the determinants of eating behaviour in children and adolescents of eight European countries and related health outcomes was built on the IDEFICS cohort (<http://www.ideficsstudy.eu>), established in 2006 and followed-up in 2012--2013. A full description of the project has been recently published^[@CR27]^.

Briefly, the Italian cohort of the I.Family project was composed by 1521 children and teens (773 NW, 748 OW/Ob) who underwent a general examination module^[@CR27]^. Among them, 249 participants (121 NW, 128 OW/Ob), identified on the basis of their body weight trajectories over the 6 year follow-up, underwent additional examinations, including the collection of a fasting urine sample. Among the 249 participants asked to provide an additional 50 ml fasting urine sample, a subsample of 28 NW and 21 OW/Ob participants accepted, and was included in the present analysis.

In particular, weight, to the nearest 0.1 kg with children wearing light clothes and without shoes was measured using an electronic scale (TanitaBC420SMA,Tanita Europe GmbH, Sindelfingen, Germany). Height was measured using a telescopic height-measuring instrument (Seca 225 stadiometer, Birmingham, UK) to the nearest 0.1 cm. BMI was calculated as weight (in kg) divided by height squared (in m^2^). A detailed description of the anthropometric measurements, including intra- and inter-observer reliability, has been previously published^[@CR28]^. Weight categories were defined according to age- and sex-specific BMI categories^[@CR29]^.

Each individual on the day of the physical examination provided a sample of morning urine (after overnight fasting) in a 50 mL sterile PVC container. Samples were immediately frozen and stored at −80 °C until analysis. The complete defrosting of the samples was performed at room temperature shortly before analysis. Dietary intake of the previous 24 h was assessed using an online 24-h dietary recall assessment program based on the validated offline version^[@CR30]^.

Children were asked to participate, on voluntary basis, in fasting blood withdrawal. A detailed description of sample collection and analytical procedures has been published by Peplies *et al*. (2010)^[@CR31]^.

Specifically, serum insulin was measured through enzyme-linked immunosorbent assay kit (MODULAR E170, Roche Diagnostics). Insulin resistance was estimated by the Homeostatic Model Assessment (HOMA-IR), using the following formula: HOMA-IR = \[serum insulin (mU/L) × blood glucose (mmol/L)\]/22.5^[@CR32]^.

The study protocol was approved by the local Ethics Committee of the local Health Authority (ASL Avellino) and informed written parental consent was obtained for each participant. All experiments were performed in accordance with relevant guidelines and regulations.

Chemicals and reagents {#Sec9}
----------------------

2-β-pinene (97% purity), 2-octanone (98% purity), 4-hexen-ol (96% purity), ethyl-nonanoate (98% purity), trans-2-decenal (92% purity), and aniline (98% purity) were used as internal standards, and were all produced by Sigma-Aldrich. Stock solution of these six standards, at a concentration of 1000 ppm, were prepared by dissolving the standards in a mixture of Mill-Q water and ethanol (95/5 (v/v)), and were stored in a refrigerator at 4 °C.

Ethanol was purchased from Romil. Ultra-pure water from a Milli-Q system (Millipore, Bedford, MA, USA) with a conductivity of 18 MΩ was used throughout.

Sodium chloride (NaCl), potassium carbonate (K~2~CO~3~) and potassium hydroxide (KOH) were from Sigma-Aldrich, and hydrogen chloride (HCl) was from Carlo Erba. Helium at a purity of 99.999% (Rivoira, Milan) was used as the GC carrier gas. The SPME fibers and the glass vials were purchased from Supelco (Bellofonte, PA, USA). The capillary GC-MS column HP-Innowax (30 m × 0.25 mm × 0.5μm) was obtained from Agilent J&W (Agilent Technologies Inc. Santa Clara, CA).

The SPME fibers were conditioned as suggested by the manufacturer, prior to their first use. Before the initially daily analysis, the fibers were conditioned for 5 min at the operating temperature of the GC injector port and the blank level was checked. Triplicate analyses were performed.

Sample preparation and SPME procedure {#Sec10}
-------------------------------------

Volatiles profiling was performed using the headspace SPME GC-MS method described by Cozzolino *et al*. (2014), with a DVB/CAR/PDMS (50/30 μm) fibre, an extraction temperature of 40 °C and an extraction time of 30 min.

The pH of urine samples can be an important aspect in affecting the extraction of VOCs. Although both ionized and un-ionized forms of acidic and basic VOCs exist in urine, only the un-ionized forms are volatile and can be found in the headspace. Consequently, in order to provide a profile that represents the true concentrations of VOC components in urine, here urine samples were analysed both under acid and alkaline pH, following two different sample preparation procedures, as shown below^[@CR9]^.Acid conditions (pH 1--2): in a 20 mL screw-on cap HS vial (Supelco, Bellefonte, PA, USA), 4 mL urine were added to 1 mL water, approximately 3 g NaCl and 100 μL 6 mol L^−1^ HCl;Alkaline conditions (pH 12--14): 4 mL urine, 1 mL water, approximately 3 g K~2~CO~3~ and one pellet KOH were mixed in the HS vial.

In each sample12.5 μL from a stock solution of the six internal standards (2-β-pinene, 2-octanone, 4-hexen-ol, ethyl-nonanoate, trans-2-decenal, and aniline) at a concentration of 25 ppb were added.

After stirring, vials were sealed with a Teflon (PTFE) septum and an aluminium cap (Chromacol; Fisher, Loughborough, UK) for the release of volatile compounds in the vial and enable analysis.

The sample vial was placed in the instrument dry block-heater and held at 40 °C for 30 min to equilibrate the system. The extraction and injection processes were automatically performed using an autosampler MPS 2 (Gerstel, Mülheim, Germany). Finally, the fibre was automatically inserted through the vial's septum for 10 min, to allow the volatiles adsorption onto the SPME fibre surface.

Gas chromatography--mass spectrometry analysis {#Sec11}
----------------------------------------------

The SPME fibre was introduced into the injector port of the gas chromatograph (model 7890 A; Agilent Technologies, Santa Clara, CA) coupled with a mass spectrometer 5975 C (Agilent), wherein the metabolites were thermally desorbed and directly transferred to a capillary column HP-Innowax (30 m × 0.25 mm × 0.5 μm; Agilent) for analysis.

The oven temperature program was initially set at 35 °C for 5 min, ramped to 120 °C at 5 °C min^−1^, increased to 250 °C at 10 °C min^−1^, and held for 10 min. The temperature of the ion source and the quadrupole were held at 230 °C and 150 °C, respectively; helium was used as carrier gas with a flow of 1.5 mL min^−1^; injector temperature was kept at 240 °C and the pulsed splitless mode was used for the analysis.

The fibre was maintained in the injector for 25 min. Mass spectra were acquired at an ionization energy of 70 eV and volatile components were detected by mass selective detector. The detector operated in a mass range between m/z 30 and 300 with a scan rate of 2.7 scans/s. Each sample was analysed in triplicate in a randomized sequence where blanks, related to analyses of coating fibre not submitted to any extraction procedure, were run.

Metabolites identification was accomplished by searching mass spectra in the available database libraries (NIST, version 2005; Wiley, version 2007) and by the comparison of their retention times with an in-house developed retention time library based on commercial standards. Furthermore, identification of volatile compounds was also achieved by matching their retention indices (RI) (as Kovats indices; Kovats, 1958) with literature data, determined relative to the retention time of a C~8~-C~20~ n-alkanes series, with those of authentic compounds or literature data.

Metabolite concentration was determined by calculating the ratio of the peak area of the metabolite and the peak area of the related internal standard. After the calculation of the median of the triplicates, the obtained data sets were log-transformed and autoscaled.

Statistical analysis {#Sec12}
--------------------

The collected data were investigated by multivariate and univariate statistical data analysis.

Specifically, exploratory data analysis was performed by Principal Component Analysis (PCA), whereas Projection to Latent Structures Discriminant Analysis based on Variable Influence on Projection selection (PLS-DA VIP-based) was applied to identify the differences between OW/Ob and Nw children. Stability selection based on Monte-Carlo sampling was used to highlight the subset of relevant variables characterizing the two groups and to estimate the predictive power of the models^[@CR33]^. During stability selection, three hundred random subsamples of the collected samples were extracted by Monte-Carlo sampling (with a prior probability of 0.70), and then PLS-DA VIP-based was applied to each subsample, obtaining a set of 300 discriminant models. The predictive performance of each model was estimated by means of Receiver Operating Characteristic (ROC) curve analysis of the outcomes of the predictions of which samples would be excluded during sub-sampling. Within this set of PLS-DA VIP-based models, the most frequently selected variables were identified as relevant variables. The threshold of VIP to use for variable selection was determined maximizing the Q2 parameter (i.e. R2 calculated by cross-validation) during 7-fold cross-validation. Models were submitted to permutation test on the class response to avoid over-fitting according to good practice for model building.

ROC analysis and t-test with False Discovery Rate were applied to investigate the properties of single variable. We considered VOCs with t-test p-value less than 0.05, q-value less than 0.1 and AUC ROC greater than 0.50 (α = 0.05) as significant variables. The results of the multivariate data analysis were merged to those obtained by univariate data analysis to have a comprehensive data analysis, where both the correlation structures and the individual properties of the measured variables were taken into account.

PCA, PLS-DA VIP-based with stability selection, ROC analysis and t-test with False Discovery Rate were implemented with the R 3.1.2 platform (R Foundation for Statistical Computing).

Data availability {#Sec13}
-----------------

The datasets generated during and/or analysed during the current study are not publicly available according to the conditions laid down in the Consortium Agreement of the I.Family project (EC FP7 Grant Agreement No. 266044) but are available from the corresponding author on reasonable request.

**Publisher\'s note:** Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

The work was done as part of the I.Family Study (<http://www.ifamilystudy.eu/>). We gratefully acknowledge the financial support of the European Community within the Seventh RTD Framework Programme Contract No. 266044 for the I.Family study.

R.C. and A.S. conceived and designed the study and wrote the paper; B.D.G. and A.M. performed the experiments; P.M. and A.M. acquired and processed data; F.L. and M.S. performed statistical analysis; P.R. contributed to the discussion of the data and critically revised the manuscript; K.G. managed the biobank. All authors reviewed the manuscript.

Competing Interests {#FPar1}
===================

The authors declare that they have no competing interests.
